-
Dec 2, 2022, 10:33 AM
by
Full story
-
Dec 2, 2022, 01:00 AM
by
User Not Found
Bio-IT World | As digital transformation in the life sciences industry continues, the user experiences (UX) of researchers and scientists interacting with technology and data is coming under closer scrutiny. One area where attention is needed is the role of UX in improving digital accessibility. Better UX for all users will drive innovation, helping to make connections between data and accelerating collaboration.
Full story
-
Dec 1, 2022, 09:49 AM
by
The Mobile Health/Central Lab Interface, an opportunity for DCT efficiency
How streamlining relations between central labs and mobile health providers can get the most from hybrid and decentralised clinical trials
Full story
-
Dec 1, 2022, 09:47 AM
by
The NHS could save up to £360M per year by using FFP3 face masks – the NHS already has a large stockpile of these masks so there is no current need to purchase more. Independent studies commissioned by PPE manufacturer Globus Group and carried out by York Economic Health Consortium and Vital Economics confirm that these masks may be better at preventing respiratory infection and resulting staff days off.
Full story
-
Dec 1, 2022, 09:46 AM
by
Full story
-
Dec 1, 2022, 09:34 AM
by
Full story
-
Dec 1, 2022, 09:34 AM
by
Full story
-
Dec 1, 2022, 09:33 AM
by
Full story
-
Dec 1, 2022, 09:26 AM
by
VisualDx has teamed up with Emergence Health Holdings, an urgent care network across New England, to grant its providers access to AI-fueled assistive technology to support diagnosis and treatment.
Amid concurrent crises, staff shortages, and other challenges in medicine, VisualDx is collaborating with an array of organizations to arm clinicians with tech that helps them do their jobs better, faster, and more accurately. In addition to Emergence, the company also recently teamed up with the Vermont Department of Health, HHS’s Biomedical Advanced Research and Development Authority, and the American College of Emergency Physicians to help clinicians diagnose and treat everything from Covid to Monkeypox, polio, the flu, and more.
Full story
-
Nov 30, 2022, 09:30 AM
by
Full story
-
Nov 30, 2022, 09:30 AM
by
Full story
-
Nov 30, 2022, 09:30 AM
by
Full story
-
Nov 30, 2022, 09:27 AM
by
Genezen appoints Jeff Whitmore as Chief Commercial Officer
Full story
-
Nov 30, 2022, 09:27 AM
by
Patent-protected Motif data capture interface from uMotif was proven as an equivalent method to capture Patient Reported Outcome and eDiary data, eliminates reliance on text-based instruments, in a study with 55 participants in 2 randomized groups conducted by SAFIRA Clinical Research at Dublin City University.
Full story
-
Nov 30, 2022, 01:00 AM
by
User Not Found
Bio-IT World | An artificial intelligence-based framework that assesses the effectiveness of novel cancer therapies in real time; three new AI-rare disease partnerships; a cross-border federated network of national genome collections for biomedical research and personalized medicine solutions; multi-scale precision cardiology platforms and heart-on-a-chip technology aimed at developing the infrastructure for a digital replica of an individual’s heart; and more.
Full story
-
Nov 29, 2022, 09:32 AM
by
Full story
-
Nov 29, 2022, 09:32 AM
by
Full story
-
Nov 29, 2022, 09:31 AM
by
Full story
-
Nov 29, 2022, 09:31 AM
by
Full story
-
Nov 29, 2022, 01:00 AM
by
User Not Found
Bio-IT World | Funding for first-in-class peptide-drug conjugate for tumor cells, gene delivery research and development, next-generation orthopedic products, and more.
Full story